UNSPSC 51292604: Ftormetazine

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1P441EE1PH. European Medicines Agency schedules Ftormetazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07822MIG. Ftormetazine generally arises in the molecular formula C21H22F3N3OS.

UNSPSC 51292604 Ftormetazine is a Commodity code that does not align with the recent state and local opportunities posted under it. The source records show solicitations for naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products through a cooperative purchasing vehicle, and a Texas HHS direct-to-manufacturer prescription program inquiry — none of which involve ftormetazine specifically. The mismatch suggests either a cataloging error in how opportunities were tagged or that state and local procurement offices are using this code as a placeholder for a broader pharmaceutical acquisition category that does not correspond to its nominal scope.

The issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving Minnesota and Oregon). Recent activity includes an IFB for naloxone and drug deactivation systems procurement from Seminole County with a July 26, 2023 response deadline, an RFI from Texas HHS posted April 3, 2026 to explore direct-to-manufacturer prescription programs, and an RFP from MMCAP issued January 20, 2026 with a March 26, 2026 proposal deadline for generic pharmaceuticals and OTC products through authorized wholesalers. The code shows no identifiable concentration among repeat buyers and lacks recent activity that would signal strong procurement velocity under its stated product definition.